Atropos Health

Name: Curated, therapeutically-organized de-identified real-world evidence network: 300M+ patient records combining EMR, clinical labs, open and closed claims, disease-registry feeds and unstructured clinical notes, with depth in oncology/hematology (stage, histology/mutation, tumor size and grade) plus dermatology and ophthalmology; sold by therapeutic area rather than as one monolithic asset, and additionally surfaced as benchmark/QA evidence for clinical LLMs
Creator: Atropos Health

ATROPOS HEALTHManage supplier listing

Curated, therapeutically-organized de-identified real-world evidence network: 300M+ patient records combining EMR, clinical labs, open and closed claims, disease-registry feeds and unstructured clinical notes, with depth in oncology/hematology (stage, histology/mutation, tumor size and grade) plus dermatology and ophthalmology; sold by therapeutic area rather than as one monolithic asset, and additionally surfaced as benchmark/QA evidence for clinical LLMs

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Atropos Health and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: Health Care Technology
Instruments: equities
Categories: AlternativeFundamentalReference

Dataset card

Type: not stated
Format: Tabular (harmonized EHR, labs, claims and registry records) plus Text (unstructured clinical notes, used as retrieval evidence for clinical language models) — no imaging modality advertised
Volume: 300M+ de-identified patient records spanning EMR, labs, claims, registries and unstructured notes; byte volume not disclosed
Users: Request further research — network-side participant count is not printed on this page; the visible scale signal is 300M+ de-identified patient records under management and a health-system plus life-science customer base at a ~95-person Series B company, so institutional accounts are plausibly in the tens-to-low-hundreds rather than thousands
History: 10 years
Update frequency: not stated
Growth: Active — new precision-medicine benchmark published September 2026, an expanding AI-agent product family on the data (evidence agent, conversational query, automation and quality-scoring tools) and continued Series B funding
Launched: ~2018-2019 (company founded in Palo Alto building clinician-facing real-world evidence tooling; the licensed evidence-network packaging followed)
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site